IDWeek 2015: HIV

IDWeek 2015: HIV

Novel Drug Candidate Could Block Every Strain of HIV

ATV+c or ATV+r With FTC/TDF: Effective Options for All Patients with HIV?

The combination of either atazanavir plus cobicistat (ATV+c) or atazanavir plus ritonavir (ATV+r) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) is an effective treatment option for patients who are infected with HIV regardless of race, sex, and age, with high and similar virologic success rates, a Week 48 subgroup analysis of a randomized Phase 3 trial confirmed at IDWeek 2015.